Published Online
on November 22, 2004

A more recent version of this article appeared on December 7, 2004

This Article Full Text (PDF) All Versions of this Article: 110/23/3573    most recent 01.CIR.0000148782.37563.F8v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rafikova, O. Articles by Nudler, E. Search for Related Content PubMed PubMed Citation Articles by Rafikova, O. Articles by Nudler, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Cardiovascular Pharmacology Endothelium/vascular type/nitric oxide Related Article

Submitted on May 21, 2004
Revised on July 18, 2004
Accepted on August 2, 2004

Control of Plasma Nitric Oxide Bioactivity by Perfluorocarbons. Physiological Mechanisms and Clinical Implications

Olga Rafikova MD, Elena Sokolova MSc, Ruslan Rafikov MSc, and Evgeny Nudler PhD^*

From the Department of Biochemistry, New York University Medical Center, New York, NY.

^* To whom correspondence should be addressed. E-mail: evgeny.nudled{at}med.nyu.edu.

Background--Perfluorocarbons (PFCs) are promising blood substitutes because of their chemical inertness and unparalleled ability to transport and upload O₂ and CO₂. Here, we report that PFC emulsions also efficiently absorb and transport nitric oxide (NO).

Methods and Results--Accumulation of NO and O₂ in PFC micelles results in rapid NO oxidation and generation of reactive NO_x species. Such micellar catalysis of NO oxidation leads to formation of vasoactive S-nitrosothiols (RSNO) in vitro and in vivo as detected electrochemically. The efficiency of PFC-mediated S-nitrosation depends on the amount of PFC in aqueous solution. The optimal PFC concentration that produced the maximum level of RSNO was 1% (vol/vol). Larger PFC amounts were progressively less efficient in generating RSNO and functioned simply as NO sink. These results explain the characteristic hemodynamic effects of PFCs. Intravenous bolus application of PFC (0.14 g/kg, 1% vol/vol) to Wistar-Kyoto rats decreased mean arterial pressure significantly (-10 mm Hg over 40 minutes). PFC-induced hypotension could be further stimulated (-17 mm Hg over 140 minutes) by exogenous thiols (cysteine and glutathione). In contrast, a larger amount of PFC (1 g/kg, 7% vol/vol) exhibited a strong hypertensive effect (11 mm Hg over 40 minutes).

Conclusions--The present study reveals a physiologically significant pool of endogenous plasma NO and underscores the crucial role of the circulating hydrophobic phase in modulating its bioactivity. The results also establish PFC as a conceptually new pharmacological tool for various cardiovascular complications associated with NO imbalance.

Key words: blood pressure • hemodynamics • nitric oxide • oxygen • fluorocarbons

Related Article:

Issue Highlights
Circulation 2004 110: 3503. [Extract] [Full Text]

This article has been cited by other articles:

				B. D. Spiess Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics J Appl Physiol, April 1, 2009; 106(4): 1444 - 1452. [Abstract] [Full Text] [PDF]

				A. Arab, K. Kuemmerer, J. Wang, C. Bode, and C. Hehrlein Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 417 - 424. [Abstract] [Full Text] [PDF]

				A. Hausladen, R. Rafikov, M. Angelo, D. J. Singel, E. Nudler, and J. S. Stamler Assessment of nitric oxide signals by triiodide chemiluminescence PNAS, February 13, 2007; 104(7): 2157 - 2162. [Abstract] [Full Text] [PDF]